Luo Peng, Yu Lan, Lin Qiang, Wang Changde, Yang Dazhi, Tang Shuo
Department of Orthopaedics, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, China.
Department of Orthopaedics, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China.
Front Bioeng Biotechnol. 2020 Aug 18;8:888. doi: 10.3389/fbioe.2020.00888. eCollection 2020.
The aim of this study was to prepare a promising biomaterial for bone tissue repair and regeneration. The Strontium - calcium sulfate hemihydrate (Sr-α-CaS) scaffold incorporating gelatin microspheres (GMs) encapsulated with Ginsenoside Rg1 (Rg1) was designed. The scaffolds of Rg1/GMs/Sr-α-CaS showed sustained release of Rg1, good biocompatibility and ability of promoting osteogenic differentiation and angiogenesis . The scaffolds were implanted into animal model of cranial bone defect to characterize bone tissue repair and regeneration . From the images of Micro-CT, it was obvious that the most bone tissue was formed in Rg1/GMs/Sr-α-CaS group in 12 weeks. New bone structure, collagen and mineralization were analyzed with staining of HE, Masson and Safranin O-Fast green and showed good distribution. The expression of osteocalcin of Rg1/GMs/Sr-α-CaS indicated new bone formation in defect site. The results revealed that synergy of Rg1 and Sr showed the best effect of bone repair and regeneration, which provided a new candidate for bone defect repair in clinic.
本研究的目的是制备一种用于骨组织修复和再生的有前景的生物材料。设计了一种包含包裹人参皂苷Rg1(Rg1)的明胶微球(GMs)的半水硫酸锶钙(Sr-α-CaS)支架。Rg1/GMs/Sr-α-CaS支架表现出Rg1的持续释放、良好的生物相容性以及促进成骨分化和血管生成的能力。将该支架植入颅骨缺损动物模型以表征骨组织的修复和再生情况。从显微CT图像可以明显看出,在12周时,Rg1/GMs/Sr-α-CaS组形成的骨组织最多。通过苏木精-伊红(HE)染色、马松(Masson)染色和番红O-固绿染色对新骨结构、胶原蛋白和矿化进行分析,结果显示分布良好。Rg1/GMs/Sr-α-CaS组骨钙素的表达表明缺损部位有新骨形成。结果表明,Rg1和Sr的协同作用对骨修复和再生显示出最佳效果,为临床骨缺损修复提供了一种新的候选材料。